#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Identification of Host-Dependent Survival Factors for Intracellular through an siRNA Screen


The stable infection of host macrophages by Mycobacterium tuberculosis (Mtb) involves, and depends on, the attenuation of the diverse microbicidal responses mounted by the host cell. This is primarily achieved through targeted perturbations of the host cellular signaling machinery. Therefore, in view of the dependency of the pathogen on host molecules for its intracellular survival, we wanted to test whether targeting such factors could provide an alternate route for the therapeutic management of tuberculosis. To first identify components of the host signaling machinery that regulate intracellular survival of Mtb, we performed an siRNA screen against all known kinases and phosphatases in murine macrophages infected with the virulent strain, H37Rv. Several validated targets could be identified by this method where silencing led either to a significant decrease, or enhancement in the intracellular mycobacterial load. To further resolve the functional relevance of these targets, we also screened against these identified targets in cells infected with different strains of multiple drug-resistant mycobacteria which differed in terms of their intracellular growth properties. The results obtained subsequently allowed us to filter the core set of host regulatory molecules that functioned independently of the phenotypic variations exhibited by the pathogen. Then, using a combination of both in vitro and in vivo experimentation, we could demonstrate that at least some of these host factors provide attractive targets for anti-TB drug development. These results provide a “proof-of-concept” demonstration that targeting host factors subverted by intracellular Mtb provides an attractive and feasible strategy for the development of anti-tuberculosis drugs. Importantly, our findings also emphasize the advantage of such an approach by establishing its equal applicability to infections with Mtb strains exhibiting a range of phenotypic diversifications, including multiple drug-resistance. Thus the host factors identified here may potentially be exploited for the development of anti-tuberculosis drugs.


Vyšlo v časopise: Identification of Host-Dependent Survival Factors for Intracellular through an siRNA Screen. PLoS Pathog 6(4): e32767. doi:10.1371/journal.ppat.1000839
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000839

Souhrn

The stable infection of host macrophages by Mycobacterium tuberculosis (Mtb) involves, and depends on, the attenuation of the diverse microbicidal responses mounted by the host cell. This is primarily achieved through targeted perturbations of the host cellular signaling machinery. Therefore, in view of the dependency of the pathogen on host molecules for its intracellular survival, we wanted to test whether targeting such factors could provide an alternate route for the therapeutic management of tuberculosis. To first identify components of the host signaling machinery that regulate intracellular survival of Mtb, we performed an siRNA screen against all known kinases and phosphatases in murine macrophages infected with the virulent strain, H37Rv. Several validated targets could be identified by this method where silencing led either to a significant decrease, or enhancement in the intracellular mycobacterial load. To further resolve the functional relevance of these targets, we also screened against these identified targets in cells infected with different strains of multiple drug-resistant mycobacteria which differed in terms of their intracellular growth properties. The results obtained subsequently allowed us to filter the core set of host regulatory molecules that functioned independently of the phenotypic variations exhibited by the pathogen. Then, using a combination of both in vitro and in vivo experimentation, we could demonstrate that at least some of these host factors provide attractive targets for anti-TB drug development. These results provide a “proof-of-concept” demonstration that targeting host factors subverted by intracellular Mtb provides an attractive and feasible strategy for the development of anti-tuberculosis drugs. Importantly, our findings also emphasize the advantage of such an approach by establishing its equal applicability to infections with Mtb strains exhibiting a range of phenotypic diversifications, including multiple drug-resistance. Thus the host factors identified here may potentially be exploited for the development of anti-tuberculosis drugs.


Zdroje

1. KoulA

HergetT

KleblB

UllrichA

2004 Interplay between mycobacteria and host signalling pathways. Nat Rev Microbiol 2 189 202

2. KaufmannSH

ColeST

MizrahiV

RubinE

NathanC

2005 Mycobacterium tuberculosis and the host response. J Exp Med 201 1693 1697

3. FlynnJL

ChanJ

2001 Immunology of tuberculosis. Annu Rev Immunol 19 93 129

4. ColeST

BroschR

ParkhillJ

GarnierT

ChurcherC

1998 Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 537 544

5. GehringAJ

RojasRE

CanadayDH

LakeyDL

HardingCV

2003 The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect Immun 71 4487 4497

6. RaghavanS

ManzanilloP

ChanK

DoveyC

CoxJS

2008 Secreted transcription factor controls Mycobacterium tuberculosis virulence. Nature 454 717 721

7. RengarajanJ

BloomBR

RubinEJ

2005 Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci U S A 102 8327 8332

8. WalburgerA

KoulA

FerrariG

NguyenL

Prescianotto-BaschongC

2004 Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 304 1800 1804

9. EhrtS

SchnappingerD

2007 Mycobacterium tuberculosis virulence: lipids inside and out. Nat Med 13 284 285

10. MacMickingJD

TaylorGA

McKinneyJD

2003 Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302 654 659

11. KelleyVA

SchoreyJS

2003 Mycobacterium's arrest of phagosome maturation in macrophages requires Rab5 activity and accessibility to iron. Mol Biol Cell 14 3366 3377

12. JayachandranR

SundaramurthyV

CombaluzierB

MuellerP

KorfH

2007 Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell 130 37 50

13. ViaLE

DereticD

UlmerRJ

HiblerNS

HuberLA

1997 Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J Biol Chem 272 13326 13331

14. FrattiRA

ChuaJ

VergneI

DereticV

2003 Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci U S A 100 5437 5442

15. ShiY

MassagueJ

2003 Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 685 700

16. RenaG

BainJ

ElliottM

CohenP

2004 D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep 5 60 65

17. BainJ

PlaterL

ElliottM

ShpiroN

HastieCJ

2007 The selectivity of protein kinase inhibitors: a further update. Biochem J 408 297 315

18. WaddellDS

LiberatiNT

GuoX

FrederickJP

WangXF

2004 Casein kinase Iepsilon plays a functional role in the transforming growth factor-beta signaling pathway. J Biol Chem 279 29236 29246

19. SawyerJS

BeightDW

BrittKS

AndersonBD

CampbellRM

2004 Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain. Bioorg Med Chem Lett 14 3581 3584

20. GinsbergAM

SpigelmanM

2007 Challenges in tuberculosis drug research and development. Nat Med 13 290 294

21. WalshC

2000 Molecular mechanisms that confer antibacterial drug resistance. Nature 406 775 781

22. SchwegmannA

BrombacherF

2008 Host-directed drug targeting of factors hijacked by pathogens. Sci Signal 1 re8

23. AgaisseH

BurrackLS

PhilipsJA

RubinEJ

PerrimonN

2005 Genome-wide RNAi screen for host factors required for intracellular bacterial infection. Science 309 1248 1251

24. BrassAL

DykxhoornDM

BenitaY

YanN

EngelmanA

2008 Identification of host proteins required for HIV infection through a functional genomic screen. Science 319 921 926

25. KonigR

ZhouY

EllederD

DiamondTL

BonamyGM

2008 Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135 49 60

26. KrishnanMN

NgA

SukumaranB

GilfoyFD

UchilPD

2008 RNA interference screen for human genes associated with West Nile virus infection. Nature 455 242 245

27. PhilipsJA

RubinEJ

PerrimonN

2005 Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309 1251 1253

28. PielageJF

PowellKR

KalmanD

EngelJN

2008 RNAi screen reveals an Abl kinase-dependent host cell pathway involved in Pseudomonas aeruginosa internalization. PLoS Pathog 4 e1000031 doi:10.1371/journal.ppat.1000031

29. PrudencioM

RodriguesCD

HannusM

MartinC

RealE

2008 Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection. PLoS Pathog 4 e1000201 doi:10.1371/journal.ppat.1000201

30. KuijlC

SavageND

MarsmanM

TuinAW

JanssenL

2007 Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 450 725 730

31. YoungD

StarkJ

KirschnerD

2008 Systems biology of persistent infection: tuberculosis as a case study. Nat Rev Microbiol 6 520 528

32. GanH

LeeJ

RenF

ChenM

KornfeldH

2008 Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol 9 1189 1197

33. WarnerDF

MizrahiV

2007 The survival kit of Mycobacterium tuberculosis. Nat Med 13 282 284

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 4
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#